Please use this identifier to cite or link to this item:
https://accedacris.ulpgc.es/handle/10553/48245
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Guedes, Gema | en_US |
dc.contributor.author | Amesty, Ángel | en_US |
dc.contributor.author | Jiménez-Monzón, Roberto | en_US |
dc.contributor.author | Marrero-Alonso, Jorge | en_US |
dc.contributor.author | Díaz, Mario | en_US |
dc.contributor.author | Fernández Pérez, Leandro | en_US |
dc.contributor.author | Estévez-Braun, Ana | en_US |
dc.date.accessioned | 2018-11-23T20:06:37Z | - |
dc.date.available | 2018-11-23T20:06:37Z | - |
dc.date.issued | 2015 | en_US |
dc.identifier.issn | 1860-7179 | en_US |
dc.identifier.uri | https://accedacris.ulpgc.es/handle/10553/48245 | - |
dc.description.abstract | In this study, a series of new 4,4-diaminotriphenylmethanes was efficiently synthesized from aromatic aldehydes and 2,5-dimethoxybenzenamine under microwave irradiation in the presence of Sc(OTf)(3) as a catalyst. Antiproliferative activity was assessed by using the MCF-7 estrogen receptor (ER)-positive breast cancer cell line, and antagonist/agonist transcriptional activities were determined. Docking studies and competition studies of triphenylmethanes and radiolabeled estradiol determined that these compounds do not bind the ER, indicating that triphenylmethane-induced changes in proliferative and transcriptional activities differ from conventional mechanisms of action triggered by other selective ER modulators. | en_US |
dc.language | eng | en_US |
dc.relation | "Evaluación Preclinica de Nuevas Estructuras Quimicas Diseñadas Para Inhibir la Ruta Oncogenica Jak-Stat O Como Moduladores Selectivos de Los Receptores Estrógenos" | en_US |
dc.relation.ispartof | ChemMedChem | en_US |
dc.source | ChemMedChem [ISSN 1860-7179], v. 10 (8), p. 1403-1412 | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 230207 Química clínica | en_US |
dc.subject | 2390 Química farmacéutica | en_US |
dc.subject.other | Activated Protein-Kinase | en_US |
dc.subject.other | Solvent-Free Conditions | en_US |
dc.subject.other | Molecular docking | en_US |
dc.subject.other | Selective modulation | en_US |
dc.subject.other | Estrogen receptors | en_US |
dc.subject.other | Triarylmethanes | en_US |
dc.title | Synthesis of 4,4′-Diaminotriphenylmethanes with Potential Selective Estrogen Receptor Modulator (SERM)-like Activity | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1002/cmdc.201500148 | en_US |
dc.identifier.scopus | 84937971189 | - |
dc.identifier.isi | 000358516200012 | - |
dc.contributor.authorscopusid | 55371607800 | - |
dc.contributor.authorscopusid | 14024036100 | - |
dc.contributor.authorscopusid | 55329696800 | - |
dc.contributor.authorscopusid | 12752675300 | - |
dc.contributor.authorscopusid | 57195085150 | - |
dc.contributor.authorscopusid | 7402043998 | - |
dc.contributor.authorscopusid | 6506777525 | - |
dc.contributor.authorscopusid | 6701825073 | - |
dc.description.lastpage | 1412 | en_US |
dc.description.firstpage | 1403 | en_US |
dc.relation.volume | 10 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.contributor.daisngid | 9546817 | - |
dc.contributor.daisngid | 3211275 | - |
dc.contributor.daisngid | 19892441 | - |
dc.contributor.daisngid | 3824467 | - |
dc.contributor.daisngid | 16872573 | - |
dc.contributor.daisngid | 795544 | - |
dc.contributor.daisngid | 425077 | - |
dc.description.numberofpages | 10 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:Guedes, G | - |
dc.contributor.wosstandard | WOS:Amesty, A | - |
dc.contributor.wosstandard | WOS:Jimenez-Monzon, R | - |
dc.contributor.wosstandard | WOS:Marrero-Alonso, J | - |
dc.contributor.wosstandard | WOS:Diaz, M | - |
dc.contributor.wosstandard | WOS:Fernandez-Perez, L | - |
dc.contributor.wosstandard | WOS:Estevez-Braun, A | - |
dc.date.coverdate | Agosto 2015 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.description.sjr | 1,148 | |
dc.description.jcr | 2,98 | |
dc.description.sjrq | Q1 | |
dc.description.jcrq | Q2 | |
dc.description.scie | SCIE | |
item.fulltext | Sin texto completo | - |
item.grantfulltext | none | - |
crisitem.project.principalinvestigator | Fernández Pérez, Leandro Francisco | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.orcid | 0000-0001-7802-465X | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Fernández Pérez, Leandro Francisco | - |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
5
checked on Mar 30, 2025
WEB OF SCIENCETM
Citations
3
checked on Mar 30, 2025
Page view(s)
112
checked on Nov 9, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.